!" ""!""# " (.,=5
Φ*F
1 " !@
= = 2
>#38;6
G
!@ @*' 1
(.,=5 -#)M998/
(. ,;
G
Vector
SD/SA Promoters
Inhibitor
Anti-Tat
+
Anti-HIV
+
25 TAR/ AS Tat 5TAR 3RRE (x3) 5TAR 3RRE 5TAR 3RRE 5TAR 3RRE 5TAR 3RRE
MMP LTR + 5T3R MMP Ψ2 LTR 5T3R MMP 5T3R + MMP Ψ2 5T3R
-
MLV & internal HIV MLV & internal HIV MPSV & internal HIV MPSV & internal HIV MPSV only MPSV only
% Transient % Inhibitionb Vector Stability Inhibitiona in Clones 78 18 2/8
Titer (IU/ml) 1 x 105 1 x 105
0
1/8
5
65
84
9/9
5
44
11/11
5
6.8 x 10 81
0
8/8
0.4 x 105 89
48
9/9
5.5 x 10 55 5.8 x 10 58
! (.
,5= ! (. >#38;6 7 '
-≥8&/ @*'
2
'@
C. G
@*' '$(
780. Inhibition of HIV-1 Reactivation by SV40 Mediated Gene T ransfer of Catalase Transfer Francisco J. Branco, David S. Strayer. 1 Pathology, Thomas Jefferson University, Philadelphia, Pennsylvania, United States. (
3 -@)(/
C."8
C."8 3 *? - @)(/ 0 (.69
-(. / C."8 C,), *?
C."8-48/>3
48 -
*C '$( @ /
C. $*' (. "
"
(.69 $*' (.69
)3 "&,9 3 G
(. "
48 $C@8,= 8# C,), ,99 % *? @)(
C."8
48
C,), *?
, " ,6
>D(' 8& -
*C '$( @ / <
$*' C."D @ @)( C."8 D @
8& (. ? E
@)(
, " 3 G
48 (.
48 B, %
,B % "
0
48
$C@8,=
C,), *?
48
48 @)(
(. 3 "
C. 48
,6 Molecular Therapy Vol. 5, No. 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy
(. "
48
48
C,),-6;=:9% / *?-5::&=% / C."8 D @
@)(
(. (. "
8&
C,), -699 6,99 @?4 / *? -8;99 8,999 @?4 / (. "
48 3
@)(
48
C."8 C."8 D @
C,), *? > (.69
@)("
C."8
781. Inhibiting HIV in Primary Lymphocyte Cultures Using Combinations of T ransgenes Delivered by Transgenes Recombinant SV40 V ectors Vectors David S. Strayer, Carmen N. Nichols, Francisco Branco. 7
3G
C.
0
(.69 1 C.
C."
(.69 C. C.
> 1
C. # 7 @ "
(.69
(.-! '@/
,& '@ 1
C."8D @' #. 7 ? F@6 -(.-C>// C."8 -(.-@ =/ (.->://# (.-C2(/ 2
! -!2D/
' (.69 -#) M 899/
= (.69 #) M 899 D",
6 89-B/ !2D
C."8*D6"=!
C."8*D6"=
789999 $&9- M998/I =9999 - M 99=/ C.
,6 >D(' @ 7 * !2D (.-C2(/"
!2D - /
C."8*D6"=
,6 ! C.
!2D (.69 "C. C.
(.-C>/ ) C. C.
.
" 1
(.69 "C.
C. 7 C. " (.69 3 7
1 0
S255